Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments

To compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession reproducibility of such measurements. Six different OCT instruments (Stratus OCT [Carl Zeiss Meditec, Inc. Dublin, CA], SOCT Copernicus [Reicher...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Investigative ophthalmology & visual science Ročník 50; číslo 7; s. 3432
Hlavní autori: Wolf-Schnurrbusch, Ute E K, Ceklic, Lala, Brinkmann, Christian K, Iliev, Milko E, Frey, Manuel, Rothenbuehler, Simon P, Enzmann, Volker, Wolf, Sebastian
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.07.2009
Predmet:
ISSN:1552-5783, 1552-5783
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract To compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession reproducibility of such measurements. Six different OCT instruments (Stratus OCT [Carl Zeiss Meditec, Inc. Dublin, CA], SOCT Copernicus [Reichert/Optopol Technology, Inc., Depew, NY], Spectral OCT/SLO [Opko/OTI, Inc., Miami, FL], RTVue-100 [Optovue Corp., Fremont, CA], Spectralis HRA+OCT [Heidelberg Engineering, Inc., Heidelberg, Germany], and Cirrus HD-OCT [Carl Zeiss Meditec, Inc.]) were used to assess CRT in both eyes of healthy subjects. Measurements were performed in two different sessions on the same day with each of the systems. From these measurements, the mean CRT was calculated. For the assessment of the intersession reproducibility of the instruments, we calculated the coefficient of the variation of test-retest variation. Twenty healthy subjects were included in the study. Compared with the Stratus OCT all spectral OCT instruments showed significantly higher CRTs. The Spectralis HRA+OCT and Cirrus HD-OCT showed similar CRT values but significantly higher values than did all other instruments. The coefficients of variation for repeated measurements was 3.33% for the Stratus OCT, 0.46% for the Spectralis HRA+OCT, 3.09% for the Cirrus HD-OCT, 2.23% for the OCT/SLO, 2.77% for the RTVue-100 OCT, and for the SOCT 3.5%, respectively. discussion. The six OCT systems provided different results for CRT. The measurements with the Stratus OCT showed the lowest thicknesses, whereas those with the Cirrus HD-OCT and Spectralis HRA+OCT yielded the highest ones. These discrepancies can be explained by the differences in the retinal segmentation algorithms used by the various OCT systems. Whereas the Spectralis HRA+OCT and Cirrus HD-OCT include the RPE layer in the retinal segmentation, the other instruments do not. The data imply that the different OCT systems cannot be used interchangeably for the measurement of macular thickness.
AbstractList To compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession reproducibility of such measurements.PURPOSETo compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession reproducibility of such measurements.Six different OCT instruments (Stratus OCT [Carl Zeiss Meditec, Inc. Dublin, CA], SOCT Copernicus [Reichert/Optopol Technology, Inc., Depew, NY], Spectral OCT/SLO [Opko/OTI, Inc., Miami, FL], RTVue-100 [Optovue Corp., Fremont, CA], Spectralis HRA+OCT [Heidelberg Engineering, Inc., Heidelberg, Germany], and Cirrus HD-OCT [Carl Zeiss Meditec, Inc.]) were used to assess CRT in both eyes of healthy subjects. Measurements were performed in two different sessions on the same day with each of the systems. From these measurements, the mean CRT was calculated. For the assessment of the intersession reproducibility of the instruments, we calculated the coefficient of the variation of test-retest variation.METHODSSix different OCT instruments (Stratus OCT [Carl Zeiss Meditec, Inc. Dublin, CA], SOCT Copernicus [Reichert/Optopol Technology, Inc., Depew, NY], Spectral OCT/SLO [Opko/OTI, Inc., Miami, FL], RTVue-100 [Optovue Corp., Fremont, CA], Spectralis HRA+OCT [Heidelberg Engineering, Inc., Heidelberg, Germany], and Cirrus HD-OCT [Carl Zeiss Meditec, Inc.]) were used to assess CRT in both eyes of healthy subjects. Measurements were performed in two different sessions on the same day with each of the systems. From these measurements, the mean CRT was calculated. For the assessment of the intersession reproducibility of the instruments, we calculated the coefficient of the variation of test-retest variation.Twenty healthy subjects were included in the study. Compared with the Stratus OCT all spectral OCT instruments showed significantly higher CRTs. The Spectralis HRA+OCT and Cirrus HD-OCT showed similar CRT values but significantly higher values than did all other instruments. The coefficients of variation for repeated measurements was 3.33% for the Stratus OCT, 0.46% for the Spectralis HRA+OCT, 3.09% for the Cirrus HD-OCT, 2.23% for the OCT/SLO, 2.77% for the RTVue-100 OCT, and for the SOCT 3.5%, respectively. discussion. The six OCT systems provided different results for CRT. The measurements with the Stratus OCT showed the lowest thicknesses, whereas those with the Cirrus HD-OCT and Spectralis HRA+OCT yielded the highest ones. These discrepancies can be explained by the differences in the retinal segmentation algorithms used by the various OCT systems. Whereas the Spectralis HRA+OCT and Cirrus HD-OCT include the RPE layer in the retinal segmentation, the other instruments do not. The data imply that the different OCT systems cannot be used interchangeably for the measurement of macular thickness.RESULTSTwenty healthy subjects were included in the study. Compared with the Stratus OCT all spectral OCT instruments showed significantly higher CRTs. The Spectralis HRA+OCT and Cirrus HD-OCT showed similar CRT values but significantly higher values than did all other instruments. The coefficients of variation for repeated measurements was 3.33% for the Stratus OCT, 0.46% for the Spectralis HRA+OCT, 3.09% for the Cirrus HD-OCT, 2.23% for the OCT/SLO, 2.77% for the RTVue-100 OCT, and for the SOCT 3.5%, respectively. discussion. The six OCT systems provided different results for CRT. The measurements with the Stratus OCT showed the lowest thicknesses, whereas those with the Cirrus HD-OCT and Spectralis HRA+OCT yielded the highest ones. These discrepancies can be explained by the differences in the retinal segmentation algorithms used by the various OCT systems. Whereas the Spectralis HRA+OCT and Cirrus HD-OCT include the RPE layer in the retinal segmentation, the other instruments do not. The data imply that the different OCT systems cannot be used interchangeably for the measurement of macular thickness.
To compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession reproducibility of such measurements. Six different OCT instruments (Stratus OCT [Carl Zeiss Meditec, Inc. Dublin, CA], SOCT Copernicus [Reichert/Optopol Technology, Inc., Depew, NY], Spectral OCT/SLO [Opko/OTI, Inc., Miami, FL], RTVue-100 [Optovue Corp., Fremont, CA], Spectralis HRA+OCT [Heidelberg Engineering, Inc., Heidelberg, Germany], and Cirrus HD-OCT [Carl Zeiss Meditec, Inc.]) were used to assess CRT in both eyes of healthy subjects. Measurements were performed in two different sessions on the same day with each of the systems. From these measurements, the mean CRT was calculated. For the assessment of the intersession reproducibility of the instruments, we calculated the coefficient of the variation of test-retest variation. Twenty healthy subjects were included in the study. Compared with the Stratus OCT all spectral OCT instruments showed significantly higher CRTs. The Spectralis HRA+OCT and Cirrus HD-OCT showed similar CRT values but significantly higher values than did all other instruments. The coefficients of variation for repeated measurements was 3.33% for the Stratus OCT, 0.46% for the Spectralis HRA+OCT, 3.09% for the Cirrus HD-OCT, 2.23% for the OCT/SLO, 2.77% for the RTVue-100 OCT, and for the SOCT 3.5%, respectively. discussion. The six OCT systems provided different results for CRT. The measurements with the Stratus OCT showed the lowest thicknesses, whereas those with the Cirrus HD-OCT and Spectralis HRA+OCT yielded the highest ones. These discrepancies can be explained by the differences in the retinal segmentation algorithms used by the various OCT systems. Whereas the Spectralis HRA+OCT and Cirrus HD-OCT include the RPE layer in the retinal segmentation, the other instruments do not. The data imply that the different OCT systems cannot be used interchangeably for the measurement of macular thickness.
Author Rothenbuehler, Simon P
Ceklic, Lala
Frey, Manuel
Wolf-Schnurrbusch, Ute E K
Enzmann, Volker
Brinkmann, Christian K
Iliev, Milko E
Wolf, Sebastian
Author_xml – sequence: 1
  givenname: Ute E K
  surname: Wolf-Schnurrbusch
  fullname: Wolf-Schnurrbusch, Ute E K
  organization: Universitätsklinik für Augenheilkunde, Bern Photographic Reading Center, Inselspital, University of Bern, Bern, Switzerland
– sequence: 2
  givenname: Lala
  surname: Ceklic
  fullname: Ceklic, Lala
– sequence: 3
  givenname: Christian K
  surname: Brinkmann
  fullname: Brinkmann, Christian K
– sequence: 4
  givenname: Milko E
  surname: Iliev
  fullname: Iliev, Milko E
– sequence: 5
  givenname: Manuel
  surname: Frey
  fullname: Frey, Manuel
– sequence: 6
  givenname: Simon P
  surname: Rothenbuehler
  fullname: Rothenbuehler, Simon P
– sequence: 7
  givenname: Volker
  surname: Enzmann
  fullname: Enzmann, Volker
– sequence: 8
  givenname: Sebastian
  surname: Wolf
  fullname: Wolf, Sebastian
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19234346$$D View this record in MEDLINE/PubMed
BookMark eNpNkL1PwzAUxC0Eoh-wMSNPbCm248TOiCq-pCIWmCPHeWlMEzvYDqL_PQGKxHTvTr93wy3QsXUWELqgZEVpLq6N-wgrIhNWCHKE5jTLWJIJmR7_u2doEcIbIYxSRk7RjBYs5SnP52j3pPTYKY9ja_TOQgi4BxVGDz3YGLCxuAXVxXaPYQ8Bj8HYLQ7mE9emacBPEHZDNFp1WLv2O9CAo-vd1qth-jI2RD_-lJ2hk0Z1Ac4PukSvd7cv64dk83z_uL7ZJJrTPCZpLhuiFNS0aDLBWa11I-uUc1EoKeVka1nJvKGSijqllagEVDkvcpIKoRvGlujqt3fw7n2EEMveBA1dpyy4MZS54HRagkzg5QEcqx7qcvCmV35f_s3DvgBNy2vm
CitedBy_id crossref_primary_10_1007_s00417_010_1400_3
crossref_primary_10_1136_bjophthalmol_2019_314096
crossref_primary_10_3928_23258160_20150323_02
crossref_primary_10_1016_j_ajo_2017_07_011
crossref_primary_10_1371_journal_pone_0080483
crossref_primary_10_1097_ICO_0000000000002157
crossref_primary_10_1016_j_ajo_2012_05_004
crossref_primary_10_3109_09286586_2014_888085
crossref_primary_10_1097_IAE_0b013e3182807683
crossref_primary_10_1186_s12886_021_02089_w
crossref_primary_10_1016_j_ophtha_2009_10_029
crossref_primary_10_12688_f1000research_2_131_v1
crossref_primary_10_12688_f1000research_2_131_v2
crossref_primary_10_1159_000362372
crossref_primary_10_3928_15428877_20111222_02
crossref_primary_10_1186_s12886_016_0232_2
crossref_primary_10_1111_j_1755_3768_2011_02112_x
crossref_primary_10_4103_njcp_njcp_318_22
crossref_primary_10_1007_s40123_021_00377_8
crossref_primary_10_3390_diagnostics13020266
crossref_primary_10_1007_s00417_014_2672_9
crossref_primary_10_1177_1120672120927664
crossref_primary_10_1100_2012_842795
crossref_primary_10_1007_s00115_012_3707_2
crossref_primary_10_1097_IAE_0b013e31820d3f13
crossref_primary_10_1371_journal_pone_0142272
crossref_primary_10_1038_s41433_024_03462_x
crossref_primary_10_1007_s00415_012_6466_x
crossref_primary_10_1097_IIO_0b013e318266bf14
crossref_primary_10_1097_IJG_0b013e3181f3eb64
crossref_primary_10_3928_15428877_20121001_06
crossref_primary_10_5301_ejo_5000630
crossref_primary_10_2165_11538130_000000000_00000
crossref_primary_10_1155_2015_847694
crossref_primary_10_1097_IAE_0000000000000093
crossref_primary_10_3109_02713683_2012_678542
crossref_primary_10_3109_02713683_2012_678543
crossref_primary_10_1186_s12886_020_01379_z
crossref_primary_10_1016_j_ophtha_2012_09_051
crossref_primary_10_5301_ejo_5000074
crossref_primary_10_1016_j_media_2011_05_012
crossref_primary_10_1007_s00417_010_1338_5
crossref_primary_10_1097_WNO_0b013e318272c7cd
crossref_primary_10_1111_cxo_13064
crossref_primary_10_1080_03007995_2017_1366662
crossref_primary_10_1177_1352458511431972
crossref_primary_10_3390_diagnostics14131320
crossref_primary_10_1089_jop_2016_0139
crossref_primary_10_1159_000430470
crossref_primary_10_3928_23258160_20250304_02
crossref_primary_10_1136_bjophthalmol_2014_305673
crossref_primary_10_3928_23258160_20180601_05
crossref_primary_10_2217_nmt_14_10
crossref_primary_10_1117_1_3275481
crossref_primary_10_1167_iovs_18_25389
crossref_primary_10_1016_j_ajo_2012_10_021
crossref_primary_10_3928_23258160_20150213_23
crossref_primary_10_1111_ceo_12724
crossref_primary_10_1007_s00417_015_3079_y
crossref_primary_10_1371_journal_pone_0019843
crossref_primary_10_1016_j_ajo_2011_04_008
crossref_primary_10_1097_WNO_0b013e3181facbbd
crossref_primary_10_3109_02713683_2015_1114651
crossref_primary_10_1117_1_3470116
crossref_primary_10_1007_s00415_013_7226_2
crossref_primary_10_1007_s10384_011_0085_4
crossref_primary_10_1038_s41746_024_01222_5
crossref_primary_10_1007_s00417_014_2685_4
crossref_primary_10_1097_NRL_0b013e31823d7acd
crossref_primary_10_4103_ijo_IJO_902_17
crossref_primary_10_1007_s00415_017_8531_y
crossref_primary_10_1111_ene_12070
crossref_primary_10_1371_journal_pone_0129005
crossref_primary_10_1007_s10792_020_01343_2
crossref_primary_10_1111_j_1755_3768_2011_02322_x
crossref_primary_10_1038_eye_2013_28
crossref_primary_10_1007_s00347_016_0224_x
crossref_primary_10_1007_s00417_013_2560_8
crossref_primary_10_1093_brain_aww219
crossref_primary_10_1007_s00417_021_05203_2
crossref_primary_10_1007_s10792_022_02569_y
crossref_primary_10_1186_s12886_022_02356_4
crossref_primary_10_3341_jkos_2025_66_5_233
crossref_primary_10_1097_IIO_0000000000000142
crossref_primary_10_1155_2018_5604632
crossref_primary_10_1007_s00417_011_1825_3
crossref_primary_10_1016_j_jns_2014_06_031
crossref_primary_10_1080_03007995_2017_1366659
crossref_primary_10_1016_j_ajo_2011_08_008
crossref_primary_10_3389_fmed_2025_1529719
crossref_primary_10_4103_ojo_ojo_21_23
crossref_primary_10_1016_j_exer_2014_10_003
crossref_primary_10_1016_j_ophtha_2011_07_002
crossref_primary_10_3928_23258160_20170329_06
crossref_primary_10_1097_IAE_0b013e31825620ba
crossref_primary_10_1097_IAE_0000000000002111
crossref_primary_10_1097_IAE_0000000000000177
crossref_primary_10_1117_1_3573817
crossref_primary_10_3109_02713683_2015_1075219
crossref_primary_10_1097_ICU_0b013e32833866ae
crossref_primary_10_1111_j_1755_3768_2012_02556_x
crossref_primary_10_1097_WNO_0b013e318221b434
crossref_primary_10_1155_2016_8307639
crossref_primary_10_1016_j_ajo_2010_06_025
crossref_primary_10_1093_brain_awq146
crossref_primary_10_1097_IJG_0b013e31829521db
crossref_primary_10_1097_IJG_0b013e318287ac2f
crossref_primary_10_1097_WCO_0000000000000636
crossref_primary_10_1016_j_ajo_2011_08_025
crossref_primary_10_1016_j_jcjo_2019_12_007
crossref_primary_10_1159_000541425
crossref_primary_10_1080_03007995_2018_1560779
crossref_primary_10_1371_journal_pone_0200819
crossref_primary_10_1097_WNO_0000000000000422
crossref_primary_10_1159_000353455
crossref_primary_10_1111_aos_13087
crossref_primary_10_1007_s00417_020_04667_y
crossref_primary_10_1016_j_jns_2019_06_009
crossref_primary_10_1155_2012_564627
crossref_primary_10_1038_eye_2010_178
crossref_primary_10_5301_oapoc_0000021
crossref_primary_10_1097_IAE_0b013e318227a9ef
crossref_primary_10_1097_IAE_0000000000000111
crossref_primary_10_1136_bjophthalmol_2015_307035
crossref_primary_10_3109_02713683_2013_850099
crossref_primary_10_1111_cxo_12393
crossref_primary_10_1002_pdi_1742
crossref_primary_10_1016_j_ajo_2009_08_037
crossref_primary_10_1371_journal_pone_0177515
crossref_primary_10_1016_j_cag_2019_07_001
crossref_primary_10_1186_2051_5960_2_54
crossref_primary_10_3109_02713683_2014_952828
crossref_primary_10_3928_15428877_20111201_03
crossref_primary_10_1016_j_ophtha_2012_07_012
crossref_primary_10_1111_aos_13748
crossref_primary_10_1177_1352458510371640
crossref_primary_10_1080_09500340_2015_1045309
crossref_primary_10_1007_s00417_011_1725_6
crossref_primary_10_1016_j_ajo_2015_05_015
crossref_primary_10_5301_ejo_5000582
crossref_primary_10_1016_j_sjopt_2014_02_010
crossref_primary_10_5301_ejo_5000581
crossref_primary_10_1016_j_cyto_2022_155807
crossref_primary_10_1097_IAE_0000000000001323
crossref_primary_10_1556_OH_2013_29785
crossref_primary_10_3928_15428877_20120618_05
crossref_primary_10_1016_j_pdpdt_2022_102741
crossref_primary_10_1177_1120672118795062
crossref_primary_10_3109_02713683_2010_481069
crossref_primary_10_1016_j_ajo_2019_02_038
crossref_primary_10_1136_bjo_2022_321766
crossref_primary_10_1016_j_ajo_2012_07_030
crossref_primary_10_1007_s00417_014_2640_4
crossref_primary_10_1001_jamaophthalmol_2018_1319
crossref_primary_10_1016_j_sjopt_2014_10_003
crossref_primary_10_1016_j_ajo_2010_11_019
crossref_primary_10_1016_j_ajo_2010_03_015
crossref_primary_10_1371_journal_pone_0128925
crossref_primary_10_1097_IAE_0000000000001458
crossref_primary_10_1136_bjophthalmol_2014_306482
crossref_primary_10_3928_15428877_20100325_01
crossref_primary_10_1016_j_ajo_2011_09_032
crossref_primary_10_1016_j_ophtha_2009_08_039
crossref_primary_10_1016_j_expneurol_2022_114119
crossref_primary_10_1371_journal_pone_0180462
crossref_primary_10_1080_17469899_2024_2362162
crossref_primary_10_1371_journal_pone_0036155
crossref_primary_10_1007_s00417_014_2713_4
crossref_primary_10_1080_09273948_2022_2075761
crossref_primary_10_1097_IAE_0000000000002557
crossref_primary_10_1186_s12938_016_0206_x
crossref_primary_10_1093_brain_awx088
crossref_primary_10_3109_13816810_2013_804095
crossref_primary_10_1111_j_1755_3768_2012_02562_x
crossref_primary_10_46889_JOAR_2025_6302
crossref_primary_10_1038_s41598_024_54109_6
crossref_primary_10_1371_journal_pone_0162001
crossref_primary_10_1038_s41598_022_13312_z
crossref_primary_10_1186_s40942_018_0111_5
crossref_primary_10_1155_2015_136295
crossref_primary_10_1186_s13023_015_0318_6
crossref_primary_10_1186_s40942_018_0144_9
crossref_primary_10_1111_j_1755_3768_2011_02145_x
crossref_primary_10_1007_s00417_010_1463_1
crossref_primary_10_1177_1352458510365156
crossref_primary_10_1371_journal_pone_0087996
crossref_primary_10_1007_s00417_017_3710_1
crossref_primary_10_3109_02713683_2015_1043134
crossref_primary_10_1097_IAE_0000000000001631
crossref_primary_10_3390_ph17101357
crossref_primary_10_1517_17530059_2012_719496
crossref_primary_10_5301_ejo_5000768
crossref_primary_10_1167_iovs_18_23813
crossref_primary_10_1155_2012_530305
crossref_primary_10_1371_journal_pone_0131154
crossref_primary_10_1111_aos_13706
crossref_primary_10_1007_s00784_018_2410_5
crossref_primary_10_1016_j_ajo_2010_05_037
crossref_primary_10_1016_j_ajo_2015_03_027
crossref_primary_10_1111_opo_13393
crossref_primary_10_1364_OE_19_014568
crossref_primary_10_1097_IAE_0000000000003158
crossref_primary_10_1097_IAE_0000000000000433
crossref_primary_10_1016_j_ajo_2011_06_010
crossref_primary_10_1097_IAE_0b013e3182019be2
crossref_primary_10_1007_s00417_015_3075_2
crossref_primary_10_1007_s10384_012_0192_x
crossref_primary_10_1016_S1474_4422_10_70168_X
crossref_primary_10_1093_brain_awt221
crossref_primary_10_1212_WNL_0000000000004736
crossref_primary_10_1016_j_jcjo_2013_02_013
crossref_primary_10_5301_ejo_5000437
crossref_primary_10_1007_s00417_013_2346_z
crossref_primary_10_1007_s00417_013_2454_9
crossref_primary_10_1007_s40135_013_0019_z
crossref_primary_10_1117_1_JBO_17_6_066013
crossref_primary_10_1016_j_exer_2016_05_013
crossref_primary_10_1097_IAE_0000000000000325
crossref_primary_10_4102_aveh_v77i1_448
crossref_primary_10_1167_tvst_7_4_8
crossref_primary_10_1007_s00216_011_5052_x
crossref_primary_10_1016_j_ajo_2010_04_019
crossref_primary_10_1155_2011_692574
crossref_primary_10_3109_02713683_2013_787433
crossref_primary_10_1007_s00417_010_1415_9
crossref_primary_10_1136_bjophthalmol_2013_304345
crossref_primary_10_1111_tmi_13862
crossref_primary_10_1016_j_ajo_2012_02_003
crossref_primary_10_1007_s00417_014_2799_8
crossref_primary_10_1038_eye_2011_293
crossref_primary_10_3109_02713683_2015_1135961
crossref_primary_10_1016_j_ophtha_2016_09_021
crossref_primary_10_1080_02713683_2017_1396615
crossref_primary_10_1016_j_optom_2024_100519
crossref_primary_10_1007_s00417_011_1630_z
crossref_primary_10_1371_journal_pone_0221466
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1167/iovs.08-2970
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1552-5783
ExternalDocumentID 19234346
Genre Journal Article
Comparative Study
GroupedDBID ---
.55
.GJ
18M
2WC
34G
39C
53G
5GY
5RE
ACGFO
ACNCT
ADBBV
AENEX
AFFNX
AFOSN
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GROUPED_DOAJ
GX1
N9A
NPM
OK1
P2P
RPM
SJN
TR2
TRV
VH1
W8F
WH7
WOQ
WOW
X7M
ZGI
ZXP
7X8
ID FETCH-LOGICAL-c416t-368f0aaed19f5742dccf8d34479a888dccd8b86f1817d31b7b7eb64960377cf22
IEDL.DBID 7X8
ISICitedReferencesCount 332
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000267292100052&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1552-5783
IngestDate Thu Sep 04 18:20:07 EDT 2025
Thu Apr 03 07:03:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c416t-368f0aaed19f5742dccf8d34479a888dccd8b86f1817d31b7b7eb64960377cf22
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 19234346
PQID 67412110
PQPubID 23479
ParticipantIDs proquest_miscellaneous_67412110
pubmed_primary_19234346
PublicationCentury 2000
PublicationDate 2009-07-01
PublicationDateYYYYMMDD 2009-07-01
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-07-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2009
SSID ssj0021120
Score 2.4708476
Snippet To compare central retinal thickness (CRT) measurements in healthy eyes by different commercially available OCT instruments and to compare the intersession...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 3432
SubjectTerms Adult
Anatomy, Cross-Sectional
Body Weights and Measures
Female
Humans
Male
Middle Aged
Reproducibility of Results
Retina - anatomy & histology
Tomography, Optical Coherence - instrumentation
Tomography, Optical Coherence - standards
Title Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments
URI https://www.ncbi.nlm.nih.gov/pubmed/19234346
https://www.proquest.com/docview/67412110
Volume 50
WOSCitedRecordID wos000267292100052&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6qFfHi-1Gfe_C62maTbAKCiFi8tPSg0FvZ3exqKE2qicX-e2c2iZ7Eg5dAIBnCZnb2m9c3hFwi161UHmwkbhXzE6NYxJVgEqB_EACEtla5YRNiOIzG43jUIjdNLwyWVTY20RnqJNcYI78O4ehDZ-V2_sZwZhTmVusBGiukzQHIoE6L8XcOAR52pIzIMcZAL3lT9h6K6zRfFFddbD8Q3d-hpTti-lv_-7htsllDS3pX6cIOaZlsl6wP6uT5HpkOpCs6pVjiPkUTR2c_EcKCphmtuiKX1CxNQbEk_oUW6SdtpqiUNJ-72DfV-WvVJ0jLfFazXoMAZKN1wvbJc__h6f6R1bMWmAZIVjIeRrYrpUl6sQ3AXU60tlGCdICxBCcZbpNIRaEFQCAS3lNC4TAVH_wfLoS2nndAVrM8M0eEauvHvpaeBE_F79lAKaWt8CwHW6ZARodcNIs4AV3GBIXMTP5RTJpl7JDD6j9M5hXlxgRxqM_98PjPd0_IRpXwwYraU9K2sIvNGVnTizIt3s-disB1OBp8AeN3yhA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macular+thickness+measurements+in+healthy+eyes+using+six+different+optical+coherence+tomography+instruments&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Wolf-Schnurrbusch%2C+Ute+E+K&rft.au=Ceklic%2C+Lala&rft.au=Brinkmann%2C+Christian+K&rft.au=Iliev%2C+Milko+E&rft.date=2009-07-01&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=50&rft.issue=7&rft.spage=3432&rft_id=info:doi/10.1167%2Fiovs.08-2970&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon